Related references
Note: Only part of the references are listed.Efficacy and safety of drugs for nonalcoholic steatohepatitis
Bo Shen et al.
JOURNAL OF DIGESTIVE DISEASES (2021)
Mtu1 defects are correlated with reduced osteogenic differentiation
Qiufen He et al.
CELL DEATH & DISEASE (2021)
Adiponectin Inhibits NLRP3 Inflammasome Activation in Nonalcoholic Steatohepatitis via AMPK-JNK/ErK1/2-NFκB/ROS Signaling Pathways
Zhixia Dong et al.
FRONTIERS IN MEDICINE (2020)
Feeding induces cholesterol biosynthesis via the mTORC1-USP20-HMGCR axis
Xiao-Yi Lu et al.
NATURE (2020)
Arctigenin improves lipid metabolism by regulating AMP-activated protein kinase and downstream signaling pathways
Yuzhou Song et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Triptolide and Its Derivatives as Cancer Therapies
Pawan Noel et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Triptolide: Medicinal chemistry, chemical biology and clinical progress
Wei Hou et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
(5R)-5-hydroxytriptolide ameliorates liver lipid accumulation by suppressing lipid synthesis and promoting lipid oxidation in mice
Yunxia Dong et al.
LIFE SCIENCES (2019)
Drp1-associated mitochondrial dysfunction and mitochondrial autophagy: a novel mechanism in triptolide-induced hepatotoxicity
Muhammad Hasnat et al.
CELL BIOLOGY AND TOXICOLOGY (2019)
Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD
Daniel Garcia et al.
CELL REPORTS (2019)
The Upstream Pathway of mTOR-Mediated Autophagy in Liver Diseases
Haojie Wang et al.
CELLS (2019)
Selective Liver Estrogen Receptor Modulation Prevents Steatosis, Diabetes, and Obesity Through the Anorectic Growth Differentiation Factor 15 Hepatokine in Mice
Maeva Guillaume et al.
HEPATOLOGY COMMUNICATIONS (2019)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
AMPK: guardian of metabolism and mitochondrial homeostasis
Sebastien Herzig et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Preclinical models of non-alcoholic fatty liver disease
Prasanna K. Santhekadur et al.
JOURNAL OF HEPATOLOGY (2018)
Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-κB pathway
Xu Chen et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models
Ryan M. Esquejo et al.
EBIOMEDICINE (2018)
Pharmacological Inhibition of Fatty Acid-Binding Protein 4 (FABP4) Protects Against Rhabdomyolysis-Induced Acute Kidney Injury
Rongshuang Huang et al.
FRONTIERS IN PHARMACOLOGY (2018)
Quercetin protects mouse liver against triptolide-induced hepatic injury by restoring Th17/Treg balance through Tim-3 and TLR4-MyD88-NF-κB pathway
Cai-Bing Wei et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Critical Role of Hepatic Cyp450 sin the Testis-Specific Toxicity of (5R)-5-Hydroxytriptolide in C57BL/6 Mice
Cunzhi Yu et al.
FRONTIERS IN PHARMACOLOGY (2017)
Toxicity of triptolide and the molecular mechanisms involved
Chen Xi et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Treatment of nonalcoholic fatty liver disease: role of AMPK
Brennan K. Smith et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
NAFLD: A multisystem disease
Christopher D. Byrne et al.
JOURNAL OF HEPATOLOGY (2015)
Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
Giovanni Musso et al.
PLOS MEDICINE (2014)
Characteristics and diagnosis of NAFLD/NASH
Etsuko Hashimoto et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Knockout of hepatic P450 reductase aggravates triptolide-induced toxicity
Xiang Xue et al.
TOXICOLOGY LETTERS (2011)
The regulation of AMP-activated protein kinase by upstream kinases
D. Carling et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Share Paper
